Pesquisas alternativas:
novel theory » model theory (Expandir a Pesquisa), level theory (Expandir a Pesquisa), novel therapy (Expandir a Pesquisa)
drug dealer » drug dealers (Expandir a Pesquisa), drug dealing (Expandir a Pesquisa)
novel ther » novel ether (Expandir a Pesquisa), novel thr (Expandir a Pesquisa), novel thermo (Expandir a Pesquisa)
drug does » drug doses (Expandir a Pesquisa), drugs does (Expandir a Pesquisa), drug dose (Expandir a Pesquisa)
drug dev » drug deal (Expandir a Pesquisa), drug diet (Expandir a Pesquisa), drug demo (Expandir a Pesquisa)
drug de » drug dose (Expandir a Pesquisa), drug dna (Expandir a Pesquisa)
novel theory » model theory (Expandir a Pesquisa), level theory (Expandir a Pesquisa), novel therapy (Expandir a Pesquisa)
drug dealer » drug dealers (Expandir a Pesquisa), drug dealing (Expandir a Pesquisa)
novel ther » novel ether (Expandir a Pesquisa), novel thr (Expandir a Pesquisa), novel thermo (Expandir a Pesquisa)
drug does » drug doses (Expandir a Pesquisa), drugs does (Expandir a Pesquisa), drug dose (Expandir a Pesquisa)
drug dev » drug deal (Expandir a Pesquisa), drug diet (Expandir a Pesquisa), drug demo (Expandir a Pesquisa)
drug de » drug dose (Expandir a Pesquisa), drug dna (Expandir a Pesquisa)
1
Por Gill, Christopher J., DeSilva, Mary Bachman, Hamer, Davidson H., Keyi, Xu, Wilson, Ira B., Sabin, Lora
Publicado no AIDS Behav (2015)
“... models to capture and analyze dose timing data collected longitudinally with electronic drug monitors...”Publicado no AIDS Behav (2015)
Obter o texto integral
Obter o texto integral
Obter o texto integral
Artigo
2
Por Wang, Xue Yan, Lim-Jurado, Margaret, Prepageran, Narayanan, Tantilipikorn, Pongsakorn, Wang, De Yun
Publicado no Ther Clin Risk Manag (2016)
“... that it has very low potential for drug–drug interactions, and does not require dose adjustment in renal...”Publicado no Ther Clin Risk Manag (2016)
Obter o texto integral
Obter o texto integral
Obter o texto integral
Artigo
3
“...Identification of novel targets is a critical first step in the drug discovery and development...”
Obter o texto integral
Obter o texto integral
Obter o texto integral
Obter o texto integral
Obter o texto integral
Obter o texto integral
Artigo
4
“... pharmacokinetics and pharmacodynamics, and they frequently interact with food and other drugs, requiring...”
Obter o texto integral
Obter o texto integral
Obter o texto integral
Obter o texto integral
Obter o texto integral
Obter o texto integral
Artigo
5
Por van Rijn, Richard M., Harvey, Jessica H., Brissett, Daniela I., DeFriel, Julia N., Whistler, Jennifer L.
Publicado em 2013
Assuntos:
“...Drug Discovery and Translational Medicine...”Publicado em 2013
Obter o texto integral
Obter o texto integral
Obter o texto integral
Artigo
6
“... for decades or less-intensive hypomethylating therapy. The year 2017, however, witnessed US Food and Drug...”
Obter o texto integral
Obter o texto integral
Obter o texto integral
Obter o texto integral
Obter o texto integral
Obter o texto integral
Artigo
7
“... is one of the limitations. There are significant developments in drug delivery methods and there is a...”
Obter o texto integral
Obter o texto integral
Obter o texto integral
Obter o texto integral
Obter o texto integral
Obter o texto integral
Artigo
8
Por Chism, David D., De Silva, Dinuka, Whang, Young E.
Publicado no Expert Rev Anticancer Ther (2014)
“... receptors such as glucocorticoid receptor may substitute for androgen receptor. Drugs with novel mechanisms...”Publicado no Expert Rev Anticancer Ther (2014)
Obter o texto integral
Obter o texto integral
Obter o texto integral
Artigo
9
Por Heredia, Alonso, Latinovic, Olga S, Barbault, Florent, de Leeuw, Erik PH
Publicado no Drug Des Devel Ther (2015)
“... options due to HIV-1 resistance, side effects, or drug costs. Further, it is likely that current drugs...”Publicado no Drug Des Devel Ther (2015)
Obter o texto integral
Obter o texto integral
Obter o texto integral
Artigo
10
Por Petta, Ioanna, Lievens, Sam, Libert, Claude, Tavernier, Jan, De Bosscher, Karolien
Publicado no Mol Ther (2016)
“... to investigate the unexplored potential of PPIs in drug discovery is driven by the need to find novel therapeutic...”Publicado no Mol Ther (2016)
Obter o texto integral
Obter o texto integral
Obter o texto integral
Artigo
11
Por Hadjichrysanthou, Christoforos, Cauët, Emilie, Lawrence, Emma, Vegvari, Carolin, de Wolf, Frank, Anderson, Roy M.
Publicado no J R Soc Interface (2016)
“... immunotherapy and antiviral drugs for the treatment of infection at different times post infection. Through...”Publicado no J R Soc Interface (2016)
Obter o texto integral
Obter o texto integral
Obter o texto integral
Artigo
12
Por Berardi, Rossana, Santoni, Matteo, Morgese, Francesca, Ballatore, Zelmira, Savini, Agnese, Onofri, Azzurra, Mazzanti, Paola, Pistelli, Mirco, Pierantoni, Chiara, De Lisa, Mariagrazia, Caramanti, Miriam, Pagliaretta, Silvia, Pellei, Chiara, Cascinu, Stefano
Publicado em 2013
“...://www.clinicaltrials.gov), aimed to evaluate the efficacy and toxicity of combined approaches and to develop novel...”Publicado em 2013
Obter o texto integral
Obter o texto integral
Obter o texto integral
Artigo
13
Por de Boer, Anne H., Wissink, Jeroen, Hagedoorn, Paul, Heskamp, Iwan, de Kruijf, Wilbur, Bünder, Ralf, Zanen, Pieter, Munnik, Paul, van Rijn, Cees, Frijlink, Henderik W.
Publicado em 2007
“...PURPOSE: A new inhaler (Medspray®) for pulmonary drug delivery based on the principle of Rayleigh...”Publicado em 2007
Obter o texto integral
Obter o texto integral
Obter o texto integral
Artigo
14
Por Renna, Antonio, Vejarano, L. Felipe, De la Cruz, Ernesto, Alió, Jorge L.
Publicado no Ophthalmol Ther (2016)
“...PURPOSE: The feasibility, in terms of safety and potential efficacy, of a new drug combination...”Publicado no Ophthalmol Ther (2016)
Obter o texto integral
Obter o texto integral
Obter o texto integral
Artigo
15
Por Rossini, Maurizio, De Vita, Salvatore, Ferri, Clodoveo, Govoni, Marcello, Paolazzi, Giuseppe, Salvarani, Carlo, Adami, Silvano
Publicado em 2013
“... factor (TNF) administered monthly by subcutaneous injection. It is approved by the US Food and Drug...”Publicado em 2013
Obter o texto integral
Obter o texto integral
Artigo
16
Por De Sensi, Francesco, De Potter, Tom, Cresti, Alberto, Severi, Silva, Breithardt, Günter
Publicado no Cardiovasc Diagn Ther (2015)
“... and their relevance for mechanism-based therapeutic strategies in this setting. Advances in risk stratification, drug...”Publicado no Cardiovasc Diagn Ther (2015)
Obter o texto integral
Obter o texto integral
Obter o texto integral
Artigo
17
Por Salzano, Giuseppina, Navarro, Gemma, Trivedi, Malav S., De Rosa, Giuseppe, Torchilin, Vladimir P.
Publicado no Mol Cancer Ther (2015)
“... novel type of non-toxic and easy-to-obtain nano-device for the combined therapy of siRNA and anti-cancer...”Publicado no Mol Cancer Ther (2015)
Obter o texto integral
Obter o texto integral
Obter o texto integral
Artigo
18
Por Ursini, Francesco, Russo, Emilio, De Giorgio, Roberto, De Sarro, Giovambattista, D’Angelo, Salvatore
Publicado no Ther Clin Risk Manag (2018)
“... with the different aspects of the disease, including traditional and biological disease-modifying antirheumatic drugs...”Publicado no Ther Clin Risk Manag (2018)
Obter o texto integral
Obter o texto integral
Obter o texto integral
Artigo
19
Por Lin, De, Kostov, Rumen, Huang, Jeffrey T.-J., Henderson, Colin J., Wolf, C. Roland
Publicado no J Pharmacol Exp Ther (2017)
“... metabolites are thought to be responsible for a number of adverse drug reactions. In vitro metabolite...”Publicado no J Pharmacol Exp Ther (2017)
Obter o texto integral
Obter o texto integral
Obter o texto integral
Artigo
20
Por De, Manjarika, Ghosh, Sneha, Sen, Triparna, Shadab, Md., Banerjee, Indranil, Basu, Santanu, Ali, Nahid
Publicado no Mol Ther Nucleic Acids (2017)
“... cell lines. Here we report that a novel PS-targeting liposome, phosphatidylcholine-stearylamine (PC-SA...”Publicado no Mol Ther Nucleic Acids (2017)
Obter o texto integral
Obter o texto integral
Obter o texto integral
Artigo